D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor

Published:2005-05-27 Issue:3 Volume:68 Page:568-578
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

So Christopher H.,Varghese George,Curley Kevin J.,Kong Michael M. C.,Alijaniaram Mohammed,Ji Xiaodong,Nguyen Tuan,O'Dowd Brian F.,George Susan R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference29 articles.

1. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons

2. Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization

3. In vivo [3H]Spiperone Binding: Evidence for Accumulation in Corpus Striatum by Agonist-Mediated Receptor Internalization

4. Differential Glycosylation and Intracellular Trafficking for the Long and Short Isoforms of the D2 Dopamine Receptor

5. Evidence for Adenosine/Dopamine Receptor Interactions Indications for Heteromerization

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease;CNS & Neurological Disorders - Drug Targets;2024-04

2. Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal;Biomedicines;2023-03-14

3. Class A and C GPCR Dimers in Neurodegenerative Diseases;Current Neuropharmacology;2022-11

4. Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?;Frontiers in Pharmacology;2022-08-17

5. Visualization of differential GPCR crosstalk in DRD1-DRD2 heterodimer upon different dopamine levels;Progress in Neurobiology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3